Older Adults on Prescribed Cannabis Report Well-Being Gains, But Study Cannot Rule Out Placebo or Natural Recovery
Medical cannabis older adults UK data reveal significant self-reported well-being improvements among older patients prescribed cannabis. However, the observational registry design means these gains cannot be definitively linked to the treatment. This…
Older Adults Prescribed Cannabis in UK Show Self-Reported Well-Being Gains, But Study Design Cannot Confirm Treatment Caused Improvement
The older adults cannabis registry study from the UK shows self-reported well-being improvements after prescribed cannabis use. However, the study design lacks a control group, so treatment effects cannot be confirmed. These findings highlight the need…
Cannabis Positive Drug Screen Linked to Higher Blood Clot Risk in Older Trauma Patients
Cannabis thromboembolic risk geriatric patients is a growing concern as THC positive drug screens show higher rates of blood clots in older trauma patients. This study highlights increased DVT and PE risks in this population. Understanding these risks is…
Large Canadian Study Documents How Older Adults Use Medical Cannabis — But Cannot Prove It Works
A large Canadian study on medical cannabis older adults Canada reports that most seniors using CBD-rich oils perceive improvements in pain, sleep, and mood. However, the absence of a control group means these benefits cannot be conclusively attributed to…
Demographic Features, Health Status, and Behavioral Changes Associated with Cannabidiol Use in the Dog Aging Project
This study examines CBD use patterns companion dogs and their association with health status and behavioral changes. It provides valuable insights from the Dog Aging Project. Understanding these patterns helps inform clinical discussions about…
Parent and Caregiver Perceptions of Cannabidiol Products May Put Children at Risk
Pediatric cannabidiol exposure risks are rising alongside the growth of the CBD market. Understanding caregiver perceptions is critical to preventing unintentional exposure. This study highlights the need for improved safety education and childproof…
Canadian Real-World Evidence: Observational 24-Week Outcomes for Health Care Practitioner Authorized Cannabis
This Canadian study provides valuable insights into medical cannabis real-world effectiveness over 24 weeks. Patients authorized by health care practitioners showed improvements in pain, sleep, and anxiety. The observational design reflects actual…
Investigating Medicinal Cannabis for Muscle Spasticity and Spasms
This muscle spasticity cannabis study evaluates the effectiveness and adverse events of medicinal cannabis in patients with muscle spasticity or spasms. CBD-only products showed meaningful improvements in sleep disturbance, fatigue, and pain interference…
UK Medical Cannabis Registry: Two-Year Clinical Outcomes in Depression
The UK Medical Cannabis Registry depression outcomes provide valuable real-world evidence on cannabis-based medicinal products. This two-year case series tracked clinical improvements in mood and anxiety symptoms. The study highlights sustained benefits…
Medical Cannabis Use in France: An Observational Safety Study Based on the RECANN Registry and the Pharmacovigilance/Addictovigilance System From 2021 to 2024.
This medical cannabis safety study France analyzes adverse events from the RECANN registry between 2021 and 2024. It provides key insights into neurological, gastrointestinal, and psychiatric side effects. The study supports informed clinical decisions…
